Enhancing existing vaccines, developing technologies for biodefense vaccines

Biodefense is traditionally a term associated with defensive measures taken against biological attack. Dr Michael Kurilla, Director, Office of BioDefense Research Affairs & Associate Director for BioDefense Product Development, DMID, NIAID, NIH, DHHS, spoke at the World Vaccine Congress 2012 in Washington on the application of biodefense to existing vaccines to prevent the potential impact from future pandemics. The necessity …

Top 5 videos on influenza vaccine developments

Many groups worldwide are working in a wide-range of ongoing influenza research to find better ways to prevent, diagnose, and treat seasonal and pandemic influenza. Below you will find the top 5 video presentations from government and pharma companies delivered during the World Vaccine Congress, highlighting the latest research on influenza, regulatory landscape, vaccine coverage, immunological observations and more. The …

What you need to know: Vaccines in Emerging Markets

According to Decision Resources, "Emerging markets, particularly the BRIC markets (Brazil, Russia, India, and China), promise to be new engines for pharma growth in the face of faltering growth rates and growing challenges in the traditional stronghold major markets."  Below, we look at several issues dealing with vaccine R&D, market potential, and partnerships in emerging markets.  As these markets continue …